Canadian Journal of Gastroenterology and Hepatology / 2017 / Article / Tab 1 / Clinical Study
Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents Table 1 Basic characteristics of subjects.
Index CHC Patients Healthy Controls Number 15 10 Age (y) 48.06 ± 3.82 27.30 ± 3.40 Gender (M/f) 6/9 6/4 ALT (U/L, mean ± SE) 49.29 ± 7.47 NA AST (U/L, mean ± SE) 52.78 ± 9.39 NA HCV-RNA ( IU/mL) 6.02 ± 0.30 NA HCV-RNA genotype 1b (42%)/6a (30%)/2a (28%) NA Treatment Sofosbuvir + ledipasvir (8/15), sofosbuvir + daclatasvir (7/15) NA RVR/SVR 100% NA
CHC patients: chronic hepatitis C patients; RVB: ribavirin; RVR: rapid virological response; SVR: sustained virological response.